Pharma 2 News: Pharma 2 Latest News, Pharma 2 Today news, Pharma 2 Breaking News

According to the department of pharmaceuticals (DoP), the exercise is expected to cover around 110 medicines, including 35 patented drugs.

SC questions trade margin cap only on cancer drugs

The Supreme Court questioned the government on limiting a 30% trade margin cap to cancer drugs, raising concerns over high…

October 12, 2026 21:12 IST

Ace investors Madhusudan Kela and Sunil Singhania (Image: X/AI enhanced)

Sunil Singhania’s Rs 266 cr bet, Madhu Kela’s 20x order-book play – stocks up 100%+

Sunil Singhania’s fund has crossed the 1% mark in a chemical maker that supplies Baker Hughes and Saudi Aramco. Madhusudan…

October 10, 2026 05:15 IST

Both stocks pass the screen. What separates them is how much of their profit can be checked.

296% and 852% rallies, 5 quarters of rising profit: 2 stocks face the cash test

Both stocks have grown profit for five quarters in a row, and both have multiplied in a year. One is…

October 9, 2026 05:00 IST

The panel has been given two months from its first meeting to complete the exercise and submit its recommendations.

SC asks govt to plug gaps in pharma marketing norms

The Supreme Court has ordered the central government to form a panel to review unethical pharma marketing practices, assess regulatory…

Updated: October 9, 2026 05:19 IST

A pharma association official said the proposal would limit retailers' margins by restricting the difference between the price paid by the retailer and the MRP to 30%.

Prices of 110 anti-cancer drugs to fall sharply

The government plans to cap trade margins at 30% on 110 non-scheduled anti-cancer drugs, potentially cutting prices by up to…

October 8, 2026 20:07 IST

3 Top Pharma CDMO Stocks in India to Add to Your Watchlist

Let’s take a look at 3 top CDMO Pharma stocks you can invest in India.

October 7, 2026 14:03 IST

Experts said the proposals address several long-standing tax issues faced by the pharma industry, but could bring new compliance requirements.

GST Council may give legal backing to 90% refunds for pharma companies

The GST Council plans to give statutory backing to provisional refund releases for pharma GST claims, easing tax credit recovery…

October 5, 2026 19:57 IST

A fixed national limit could have restricted this flexibility, particularly in markets where demand and supply needs differ.

Drug panel rejects cap on wholesale licences

A national drug regulatory panel declined to cap wholesale drug licences, emphasizing regional needs and urging state vigilance to prevent…

Updated: October 3, 2026 07:13 IST

US pharma tariff relief impact on Indian pharma stocks

US Pharma Tariff Relief: Which Indian pharma stocks benefit and which face trade risk?

US pharma tariff relief has different implications for Indian drugmakers, with generic, specialty, injectable and CDMO businesses facing distinct risks…

Updated: October 2, 2026 09:04 IST

The benefit could extend to companies involved in developing and manufacturing complex medicines.

Indian drugmakers get tariff relief from the US on specialty drugs

India is among 19 jurisdictions eligible for zero tariffs on certain specialty medicines under the US Section 232 exemption, benefiting…

September 29, 2026 21:33 IST

Ind-Ra said that the revenue from the US market fell 1.7% in FY26, after growing 7.6% in the previous year.

Pharma sector eyes 10% growth in FY27 as domestic market offsets US slowdown

The Indian pharma sector is projected to grow 10% in FY27, driven by strong domestic demand, rising CDMO activity, and…

Updated: September 29, 2026 05:17 IST

Sun Pharma gets global rights to lerodalcibep; EU approves Lyrokaul

Sun Pharma gets global rights to cholesterol drug; enters $3.7 billion PCSK9 market

Sun Pharma expands its cardiovascular portfolio with global rights to lerodalcibep, an EU-approved PCSK9 inhibitor for LDL reduction.

Updated: September 28, 2026 14:14 IST

Kwality's case is built on a demonstrable model: file dossiers, secure registrations and potentially convert each successful registration into approximately USD 1.5 to $2 million of annual revenue.

700 filings, 70 countries: How this small-cap pharma stock is building its growth engine

Six manufacturing units, 700-plus regulatory filings, biosimilar clinical trials underway and a revenue model built on one principle: each new…

September 16, 2026 05:00 IST

Aurobindo Pharma gets USFDA approval for first metered-dose inhaler

Aurobindo gets USFDA nod for its first metered-dose asthma inhaler, expanding US respiratory portfolio; see launch plans and stock reaction.

September 15, 2026 15:37 IST

2 quiet pharma stocks are making very different cash bets. Add to watchlist?

Two pharma companies have caught the eyes of smart investors as they clear the tough three-filter test – ROCE, DEBT…

September 15, 2026 05:04 IST

Tariffs may raise US drug prices; manufacturing shift not easy: Lupin global CFO

The proposed 100-200% US tariffs on generic drugs could raise medicine prices or cause shortages, as drugmakers may struggle to…

Updated: September 10, 2026 14:12 IST

stock market today, share market today, FII selling, FII index futures

Monday Watchlist: Nifty eyes 23,800 floor while HUL, ITC approach make-or-break reversal zones

Nifty stays below 24,000 as FII shorts rise, while Pharma faces further weakness and FMCG nears key support amid oversold…

September 7, 2026 05:30 IST

Stock exchange trading dashboard showing Symbiotic Pharmalab shares listing flat at ₹988 on NSE and at a 1% discount of ₹978.20 on BSE against the issue price of ₹988.

Symbiotec Pharmalab makes a quiet debut

Symbiotec Pharmalab lists flat at Rs 988 on NSE and 1% lower on BSE after Rs 1,757 crore IPO; check…

September 1, 2026 10:06 IST

pharma

Related News

Trending Topics